Discover the Potential of Injectable Ferric Carboxymaltose with Wexford
Discover the Potential of Injectable Ferric Carboxymaltose with Wexford At Wexford Laboratories, we are proud to introduce a new addition to our portfolio: Injectable Ferric Carboxymaltose 50 mg/mL, an effective and efficient treatment for iron deficiency anemia, especially indicated for patients in dialysis programs. This innovative product offers multiple clinical and economic advantages, positioning it … Read more